Oppenheimer & CO Inc Tandem Diabetes Care Inc Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Oppenheimer & CO Inc holds 26,125 shares of TNDM stock, worth $862,125. This represents 0.02% of its overall portfolio holdings.

Number of Shares
26,125
Previous 5,576 368.53%
Holding current value
$862,125
Previous $224,000 394.2%
% of portfolio
0.02%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$35.21 - $47.3 $723,530 - $971,967
20,549 Added 368.53%
26,125 $1.11 Million
Q2 2024

Aug 07, 2024
SELL
$30.43 - $53.43 $85,903 - $150,832
-2,823 Reduced 33.61%
5,576 $224,000
Q1 2024

May 06, 2024
SELL
$22.09 - $35.41 $30,926 - $49,573
-1,400 Reduced 14.29%
8,399 $297,000
Q4 2023

Feb 13, 2024
BUY
$14.28 - $31.03 $139,929 - $304,062
9,799 New
9,799 $289,000
Q3 2022

Nov 14, 2022
SELL
$43.76 - $68.97 $242,955 - $382,921
-5,552 Reduced 55.04%
4,536 $217,000
Q2 2022

Aug 08, 2022
BUY
$53.22 - $123.09 $119,212 - $275,721
2,240 Added 28.54%
10,088 $597,000
Q1 2022

May 12, 2022
BUY
$101.89 - $150.09 $286,514 - $422,053
2,812 Added 55.84%
7,848 $912,000
Q4 2021

Feb 02, 2022
SELL
$118.18 - $153.21 $154,224 - $199,939
-1,305 Reduced 20.58%
5,036 $758,000
Q3 2021

Nov 12, 2021
SELL
$93.51 - $129.4 $187,861 - $259,964
-2,009 Reduced 24.06%
6,341 $757,000
Q2 2021

Aug 03, 2021
BUY
$77.0 - $100.19 $200,123 - $260,393
2,599 Added 45.19%
8,350 $813,000
Q1 2021

May 10, 2021
BUY
$81.28 - $104.34 $25,359 - $32,554
312 Added 5.74%
5,751 $508,000
Q4 2020

Feb 11, 2021
SELL
$86.4 - $121.75 $281,923 - $397,270
-3,263 Reduced 37.5%
5,439 $521,000
Q3 2020

Nov 13, 2020
SELL
$95.43 - $116.09 $87,223 - $106,106
-914 Reduced 9.5%
8,702 $988,000
Q2 2020

Aug 11, 2020
SELL
$60.05 - $98.92 $40,894 - $67,364
-681 Reduced 6.61%
9,616 $952,000
Q1 2020

May 08, 2020
SELL
$47.37 - $90.04 $1.57 Million - $2.98 Million
-33,093 Reduced 76.27%
10,297 $662,000
Q4 2019

Feb 07, 2020
SELL
$53.13 - $71.19 $471,953 - $632,380
-8,883 Reduced 16.99%
43,390 $2.59 Million
Q3 2019

Oct 31, 2019
BUY
$57.11 - $73.3 $2.1 Million - $2.7 Million
36,804 Added 237.92%
52,273 $3.08 Million
Q2 2019

Aug 09, 2019
SELL
$54.41 - $71.7 $1.74 Million - $2.29 Million
-31,940 Reduced 67.37%
15,469 $998,000
Q1 2019

Apr 24, 2019
BUY
$32.25 - $73.56 $1.08 Million - $2.46 Million
33,453 Added 239.7%
47,409 $3.01 Million
Q4 2018

Jan 29, 2019
BUY
$28.45 - $40.65 $219,065 - $313,005
7,700 Added 123.08%
13,956 $530,000
Q3 2018

Oct 26, 2018
BUY
$21.39 - $51.17 $133,815 - $320,119
6,256 New
6,256 $268,000

Others Institutions Holding TNDM

# of Institutions
361
Shares Held
72.5M
Call Options Held
3.36M
Put Options Held
229K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.12B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email